Akiram Therapeutics AB
559338-7458ActivePioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
Oversikt
- 1–4
- Ansatte
- 200–299t SEK
- Omsetning
- 2021
- Grunnlagt
Nøkkelbeslutningstakere
Marika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
+4 flere kontakter i Funnelfeedr
Beskrivelse
Akiram Therapeutics is an emerging Swedish biotechnology company dedicated to revolutionizing cancer treatment. They specialize in developing innovative, targeted radioimmunotherapy designed to treat solid tumors, particularly metastatic cancers. Their proprietary approach combines radioactive molec...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559338745801
Beslutningstakere
8 kontakter i FunnelfeedrMarika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
Fredrik Frejd
Chief Strategy Officer and Co-founder
Anja Mortensen
Chief Technology Officer and Co-founder
Tina Furebring
Project Management / Operations
Andre kontakter
Jan Zedenius
Clinical Advisor
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAcrivon AB
10–19 ansatteDeveloping targeted cancer therapies using proprietary proteomics platform.
SACRA Therapeutics AB
0 ansatteSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Affibody AB
50–99 ansatteDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
AAX Biotech AB
5–9 ansatteResearch-driven biotech advancing antibody therapies via proprietary technology.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Utforsk mer
Spørsmål om Akiram Therapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo